Connect with us

Technology

Fangzhou Designated as a 2024 National High-Tech Enterprise Amid Record Growth

Published

on

BEIJING, April 3, 2025 /PRNewswire/ — Beijing Fangyixing Information Technology Co., Ltd. (“Fangyixing”), a subsidiary of China’s leading Internet healthcare solutions provider Fangzhou Inc. (“Fangzhou” or the “Company”) (06086.HK), has been certified as a 2024 National High-Tech Enterprise, solidifying its role as a pioneer in AI-powered healthcare innovation. The designation, jointly awarded by the Beijing Science and Technology Commission, Beijing Finance Bureau and Beijing Municipal Tax Service, recognizes Fangyixing’s strengths in core intellectual property, commercialization of scientific achievements, and robust R&D management.

Dr. Xie Fangmin, founder, chairman, and CEO of Fangzhou, commented, “This honor validates our long-term commitment to R&D and empowers us to further scale AI innovations within our H2H Smart Healthcare Ecosystem. We will continue to deepen collaborations with industry leaders and accelerate the translation of cutting-edge research into accessible and life-changing healthcare solutions.”

Strong Financial Performance Driven by Robust Innovation

Fangzhou’s inaugural post-IPO annual results highlighted its dual trajectory of growth and innovation: 2024 revenue grew 11.2% YoY to RMB2.707 billion, while adjusted net profit increased by 139% YoY to RMB17.1 million. This significant growth reflects Fangzhou’s sustained investment in and focus on AI-enabled technologies as a core driver of business value and operating efficiency.

AI-Driven Growth and Strategic Vision

Fangzhou’s growth objectives are aligned with its deployment of AI models such as DeepSeek-V3 and partnerships with Tencent Health and Tencent Cloud to accelerate AI-driven healthcare solutions. Fangzhou will further strengthen its technological capabilities and accelerate the commercialization of innovations, with a goal of delivering improved user experiences for patients and customers.

About Fangzhou Inc.

Fangzhou Inc. (06086.HK) is China’s leading online chronic disease management platform, serving 49.2 million registered users and 223,000 physicians (as of December 31, 2024). The Company specializes in delivering tailored medical care and precision medicine solutions. For more information, visit https://investors.jianke.com.

About the “National High-Tech Enterprise”

The National High-Tech Enterprise designation represents China’s most prestigious recognition for technological excellence, awarded to companies that demonstrate cutting-edge innovation in priority sectors. Qualifying enterprises must demonstrate sustained R&D investment, successful commercialization of proprietary technologies, and domestic or international leadership in converting advanced research into productive applications. This certification serves as the gold standard for validating a company’s scientific capabilities and innovation-driven business model in China’s competitive tech landscape.

Media Contact

For further inquiries or interviews, please reach out to:
Xingwei Zhao Associate Director of Public Relations Email: pr@jianke.com

Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements

View original content to download multimedia:https://www.prnewswire.com/news-releases/fangzhou-designated-as-a-2024-national-high-tech-enterprise-amid-record-growth-302419591.html

SOURCE Fangzhou Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

AB DAO Partners with AB Charity Foundation

Published

on

By

Building a Trustworthy Infrastructure, Advancing Global Philanthropy Through Technology

DUBLIN, May 11, 2025 /PRNewswire/ — On May 8, 2025, AB DAO and the AB Charity Foundation jointly hosted the inaugural “Technology-Driven Philanthropy Closed-Door Forum” in Dublin, Ireland.

The forum was chaired by H.E. Bertie Ahern, Chairman of the AB Charity Foundation, former Prime Minister of Ireland, and former President of the European Commission. He delivered a keynote speech titled “Technology and Trust – A New Order for Philanthropy.”

Distinguished attendees included H.E. Olusegun Obasanjo, former President of Nigeria and former Chairperson of the African Union, as well as Mr. Malcolm Byrne, Member of the Irish Parliament and Chairman of the Committee on Artificial Intelligence. The forum featured deep discussions on how emerging technologies can empower global welfare systems.

Anthony Tsang, representing AB Chain, presented the latest technical developments, including the high-performance mainnet, cross-chain protocol AB Connect, and the gas-free transaction protocol Universal Transfer. These innovations reflect AB DAO’s vision of building a globally compliant blockchain infrastructure dedicated to philanthropy.

Key proposals from the forum will be compiled by the AB Charity Foundation and submitted to the United Nations and global partner networks to further promote the global practice of “technology for good.”

About the AB Charity Foundation

The AB Charity Foundation is a legally registered international NGO in Ireland with full legal status under EU law. Supported by AB DAO in both funding and technology, the foundation is committed to building a transparent and traceable global philanthropic infrastructure using blockchain and artificial intelligence technologies.

For more information, please visit: www.ab.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/ab-dao-partners-with-ab-charity-foundation-302451775.html

SOURCE AB Foundation

Continue Reading

Technology

Miracle-48 Launches in the U.S., Bringing Regenerative Skincare to the Forefront

Published

on

By

Beauty-Stem debuted Miracle-48™ in the U.S., featuring a patented microsphere delivery system and exosome-derived extraction. The launch event included a live performance and testimonial by actress Victoria Summer, who praised the product’s visible skin-renewing effects. Experts call it a breakthrough in medical-grade anti-aging skincare, as the brand begins its global expansion starting with the U.S. market.

LOS ANGELES, May 11, 2025 /PRNewswire-PRWeb/ — Beauty-Stem Biomedical, a biotech-driven beauty and wellness company, officially unveiled its flagship product Miracle-48™ at a high-profile brand event held in Southern California. Attended by leaders from the business, medical, and philanthropic sectors, the evening marked a significant milestone for the brand’s U.S. expansion and showcased its latest innovation in skin rejuvenation.

A Science-Based Breakthrough Years in the Making

Developed by an international R&D team led by Dr. Chai-Ching Lin, President of Power-Stem Biomedical, Miracle-48™ is the result of years of cross-disciplinary research and clinical testing. The formula blends regenerative science with modern skincare, powered by a patented microsphere delivery system that precisely carries and releases exosome-derived extraction deep into the skin’s layers.

Each milliliter contains over 100,000 microspheres and 800 million active factors, delivering 48 skin-revitalizing ingredients that help reduce fine lines, dullness, and sagging—kickstarting the skin’s natural renewal process.

Victoria Summer‘s Testimonial and Performance

International actress and singer Victoria Summer, fresh off a Best Supporting Actress win at Portugal’s FARO International Film Festival, lit up the launch with a heartfelt live performance. She also shared her personal experience using Miracle-48™, saying it made a visible difference in her skin.

“In just two months, my skin looked smoother, firmer, and more radiant,” said Victoria. “It brought back a youthful glow—and my confidence too.”

Inspired by Beauty-Stem‘s mission, she now serves as the brand’s global ambassador, supporting its message of natural beauty and wellness from the inside out.

A Promising Contender in the High-End Skincare Market

With demand growing for high-performance skincare backed by science, Miracle-48™ hits the U.S. at the right moment. “This isn’t your average moisturizer,” said Dr. Sahar Lashin, MD, PhD, founder of IntegrUtopia. “It brings medical-grade technology into daily routines—and raises the bar for what skincare can do.”

Doctors, beauty experts, and media at the event called it a “game-changer” in anti-aging, with some describing it as a modern-day fountain of youth.

Global Strategy, Local Impact

The Los Angeles launch was more than just a product reveal—it marked the first major step in Beauty-Stem‘s global growth strategy. With North America as a key market, the brand plans to build its presence through continued innovation and strategic partnerships in regenerative skincare.

Beauty-Stem remains committed to delivering high-efficacy, science-backed solutions that support both beauty and long-term skin health for customers worldwide.

Media Contact

Customer Service, Beauty-Stem Biomedical US, 1 888-341-7505, Service.us@beauty-stem.com, https://beauty-stem.com/us/index.php

View original content:https://www.prweb.com/releases/miracle-48-launches-in-the-us-bringing-regenerative-skincare-to-the-forefront-302451611.html

SOURCE Beauty-Stem Biomedical US

Continue Reading

Technology

Beijing Review: 50 Years of Growing Partnership

Published

on

By

BEIJING, May 11, 2025 /PRNewswire/ — On May 6, 1975, China and the European Economic Community, the predecessor to today’s European Union, established diplomatic relations. This historic moment opened a new chapter of friendship and cooperation.

 

Over the past half a century, both sides have championed multilateralism, deepened collaboration and achieved mutually beneficial outcomes. Their enduring efforts have played a constructive role in advancing global peace and development. A healthy and stable partnership not only serves their interests, but also helps shape a better world.

“The wise find common ground; the unwise dwell on differences.” This slightly adapted line from the earliest known text on Chinese medicine, The Yellow Emperor’s Inner Canon, reflects the spirit of cooperation between the two sides across decades and offers a guiding vision for the future.

In March 2014, shortly before his state visit to Belgium and visit to the EU headquarters, President Xi Jinping cited this ancient Chinese quote in his article published in Belgian newspaper Le Soir. The sentence emphasizes that wise people focus on shared values and embrace diversity to achieve mutual benefit; whereas the unwise amplify differences, foment conflict and invite failure.

Through this quote, Xi conveyed his hope that China and the EU will respect each other, treat each other as equals, seek common ground while respecting differences, deepen communication and stay committed to mutually beneficial cooperation. He called for finding the greatest common interests, sharing opportunities and jointly tackling challenges.

Given their differences in history and culture, social institutions and stages of development, it is only natural for China and the EU to have varying perspectives, and even disagreements, on certain issues. Like-mindedness makes for partnership, and seeking common ground while respecting differences is also a feature of partnership.

Both past experiences and present realities have shown that as long as both sides adhere to mutual respect, treat each other as equals and engage in candid dialogue, differences cannot stand in the way of dialogue, nor can disagreements impede collaboration.

To date, China and the EU have established over 70 consultation and dialogue mechanisms, covering a broad spectrum of sectors including politics, economy and trade, people-to-people exchange, science and technology, energy and the environment.

Bilateral trade expanded from just over $2.4 billion in 1975 to over $780 billion in 2024. Two-way investment, once negligible, surged to nearly $260 billion. Since its launch in 2011, the China-Europe Railway Express, dubbed the “steel camel caravan,” has reached 227 cities across 25 European countries, completing over 100,000 freight trips, and become a key link between Asia and Europe.

Throughout history, both Chinese and European civilizations have made lasting impacts on the progress of humanity. In recent years, exchanges in education, science and technology have flourished. Cultural exchange is becoming more vibrant and connections between people are growing ever closer, continuously enriching their shared stories of mutual understanding, cooperation, exchange and mutual learning.

“The wise find common ground; the unwise dwell on differences.” At the new starting point that is the 50th anniversary of diplomatic relations, China and the EU should remain true to the original aspiration of their partnership, seek common ground while respecting differences, build mutual trust and pursue mutually beneficial cooperation. Together, they will foster global peace and prosperity, as well as usher in a new, promising chapter in the next 50 years.

Comments to lanxinzhen@cicgamericas.com 

TikTok:
https://www.tiktok.com/@cachinachic/video/7501235744078515502?is_from_webapp=1&sender_device=pc&web_id=7227134149436605995

X: 
https://x.com/BeijingReview/status/1919660221942923757

Facebook:
https://www.facebook.com/BJReview/videos/1104953218058969/

Weibo:
https://weibo.com/1719349955/PqzxAvhNH

Website:
http://www.bjreview.com/Multimedia/Video/Wisdom_Without_Borders/202505/t20250506_800400638.html

View original content to download multimedia:https://www.prnewswire.com/news-releases/beijing-review-50-years-of-growing-partnership-302451741.html

SOURCE Beijing Review

Continue Reading

Trending